Skip to content

A study to compare the effect of intrathecal 0.75 (H) Ropivacaine and 0.5 %(H) Bupivacaine in orthopaedic patients undergoing lower limb surgeries under spinal anesthesia

A Prospective double blind randomised study to compare the effect of intrathecal 0.75 (H) Ropivacaine and 0.5 %(H) Bupivacaine in orthopaedic patients undergoing lower limb surgeries under subarachnoid block - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093360
Enrollment
40
Registered
2025-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.75% H Ropivacaine: Subarachnoid block using fixed dose 0.75 %H Ropivacaine Control Intervention1: SAB using 0.75% (H) ROPIVACAINE: SAB using 0.75% (H) ROPIVACAINE In orthopaedic lowe

Sponsors

Neetiksha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient for orthopaedic lower limb surgery ASAI and II BMI less than 30kg per metre sq Height in between 150 to 180 cm

Exclusion criteria

Exclusion criteria: Patient not giving cons ASA III or more Contraindication for SAB SAB converted into GA

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory block Onset and duration of motor block Two segments dermatome regression time for sensory blockadeTimepoint: 1 year

Secondary

MeasureTime frame
Time of first requirement of rescue analgesia Haemodynamic parameters bp and hr Adverse effects hypotension, bradycardia, respiratory depression, shiveringTimepoint: 1 year

Countries

India

Contacts

Public ContactNeetiksha

Pt JLNGMC ,chamba, HP

neetikshasingh@gmail.com9816200698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026